The FucO protein, a member of the group III "iron-activated" dehydrogenases, catalyzes the interconversion between L-lactaldehyde and L-1,2-propanediol in Escherichia coli. The three-dimensional structure of FucO in a complex with NAD ؉ was solved, and the presence of iron in the crystals was confirmed by X-ray fluorescence. The FucO structure presented here is the first structure for a member of the group III bacterial dehydrogenases shown experimentally to contain iron. FucO forms a dimer, in which each monomer folds into an ␣/␤ dinucleotide-binding N-terminal domain and an all-␣-helix C-terminal domain that are separated by a deep cleft. The dimer is formed by the swapping (between monomers) of the first chain of the ␤-sheet. The binding site for Fe 2؉ is located at the face of the cleft formed by the C-terminal domain, where the metal ion is tetrahedrally coordinated by three histidine residues (His200, His263, and His277) and an aspartate residue (Asp196). The glycine-rich turn formed by residues 96 to 98 and the following ␣-helix is part of the NAD ؉ recognition locus common in dehydrogenases. Site-directed mutagenesis and enzyme kinetic assays were performed to assess the role of different residues in metal, cofactor, and substrate binding. In contrast to previous assumptions, the essential His267 residue does not interact with the metal ion. Asp39 appears to be the key residue for discriminating against NADP ؉ . Modeling L-1,2-propanediol in the active center resulted in a close approach of the C-1 hydroxyl of the substrate to C-4 of the nicotinamide ring, implying that there is a typical metal-dependent dehydrogenation catalytic mechanism.
nase of Bacillus stearothermophilus, an enzyme with high levels of sequence similarity to the group III enzymes, is zinc dependent has led some authors (35) to propose that this group should be renamed the family III metal-dependent polyol dehydrogenases. The available information about the three-dimensional structure of members of this family of metalloproteins includes information for two zinc-dependent enzymes, glycerol dehydrogenase from B. stearothermophilus (35) and dehydroquinate synthase from Aspergillus nidulans (13) , and an enzyme with an unknown function from Thermotoga maritima (TM0920) (37) whose sequence is very similar to the sequence of Klebsiella pneumoniae 1,3-propanediol dehydrogenase (18) ; for this reason, TM0920 has been proposed, but not experimentally proved, to be an iron-dependent enzyme. Recently, the crystal structure of the E. coli alcohol dehydrogenase YqhD has been solved (42) . Both T. maritima TM0920 and E. coli YqhD have been shown to bind NADP ϩ , although they use distinct metal ions for catalysis (Fe 2ϩ and Zn 2ϩ , respectively). In this report we describe the three-dimensional structure of an iron-dependent type III dehydrogenase from E. coli, and in this study we confirmed experimentally the presence of an Fe 2ϩ metal ion at the active site.
MATERIALS AND METHODS
Bacterial strains and plasmids. All the strains used were E. coli K-12 derivatives. Strain ECL1 (HfrC phoA8 relA1 tonA22 T2 r ) was the wild type in this study (23) . Strains M15(pREP4) (QIAGEN) and BL21 (Pharmacia Biotech) were used to express the His 6 -tagged FucO and glutathione S-transferase (GST)-FucO proteins, respectively.
Plasmid pQE32 (QIAGEN) was used for expression of N-terminal His 6 -tagged proteins. For expression of GST fusion proteins, the polylinker of plasmid pGEX-3X (Pharmacia Biotech) was appropriately modified by introduction of a NotI restriction site upstream from the BamHI site of the polylinker in order to obtain a native protein having an N-terminal end without extra residues after factor Xa cleavage.
Growth of cells and preparation of cell extracts. Cells were routinely grown aerobically on Luria-Bertani (LB) medium, and cell extracts were prepared as described elsewhere (6) . Where indicated below, isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 mM to induce expression of the cloned genes. Ampicillin and kanamycin were used at concentrations of 100 g/ml and 50 g/ml, respectively.
Cloning, expression, and purification. The full-length fucO gene from wildtype E. coli strain ECL1 was cloned into plasmid pQE32, generating plasmid pCM1. For this construction, the fragment containing the fucO gene was obtained by PCR using primers FucO-pQE fw and FucO-pQE rev (Table 1) bearing BamHI and KpnI restriction sites, respectively. Overproduction of His 6 -tagged FucO was achieved in transformed cells of strain M15(pREP4) bearing the recombinant plasmid pCM1 after IPTG induction in LB medium containing ampicillin and kanamycin for 4 h at 37°C. Cells were harvested, and the pellets were resuspended in 50 mM sodium phosphate buffer, pH 8.0, containing 0.3 M NaCl and 5 mM 2-mercaptoethanol (buffer A) and sonically disrupted. The cell extract was centrifuged at 15,000 ϫ g for 30 min, and the supernatant was incubated with a nickel-nitrilotriacetic acid resin (QIAGEN) for 1 h with gentle shaking. After the mixture was loaded into a column, the resin was first washed with 50 mM sodium phosphate buffer, pH 6.0, containing 0.3 M NaCl, 5 mM 2-mercaptoethanol, and 10% glycerol (buffer B). Stepwise elutions were performed with buffer B containing 40 mM, 100 mM, and 200 mM imidazole to eliminate contaminant protein. His-tagged FucO was eluted with 400 mM imidazole in buffer B. The purity of the FucO preparation (Ͼ98%) and the molecular mass were verified by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and matrix-assisted laser desorption ionization-time of flight mass spectrometry, respectively. The FucO preparations used for crystallization were dialyzed against 5 mM sodium phosphate buffer and then concentrated to 10 mg/ml.
To avoid the His 6 tag in experiments in site-directed mutagenesis studies, wild-type and mutant FucO preparations were purified using the GST gene fusion system with recognition sites for factor Xa cleavage that yielded precisely the wild-type N-terminal end. The fucO gene was amplified by PCR with the FucO-pGEX fw and FucO-pGEX rev primers ( Table 1 ). The PCR fragment was digested and cloned into the NotI (blunted by nuclease S1 treatment) and BamHI restriction sites of modified plasmid pGEX-3X, yielding plasmid pCM2. In this construction the reported ATG start codon of fucO was in frame with GST. The GST-FucO fusion protein was overexpressed in strain BL21(DE3) carrying the recombinant plasmid pGEX-pCM2 after IPTG (0.5 mM) induction in LB medium containing ampicillin for 3 to 4 h at 37°C. Cells were collected by centrifugation at 4°C, and the cell pellet was suspended in phosphate-buffered saline (PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 ; pH 7.3) and sonicated on ice. The cell extract, diluted 10-fold, was applied to an affinity chromatography column containing glutathione-Sepharose 4B resin (Pharmacia) at room temperature. After the column was washed with PBS, factor Xa cleavage buffer was passed through to equilibrate the matrix before Laemmli (21) . The protein concentration was determined by using the method of Lowry et al. (26) with bovine serum albumin as the standard.
Size exclusion chromatography. Fast protein liquid chromatography was carried out on a Superdex 200 column. The purified protein (0.5 mg) in 10 mM Tris-HCl (pH 7.3) and 10% (vol/vol) glycerol was loaded onto a column previously equilibrated with the same buffer. The protein was eluted using the same buffer at a flow rate of 0.5 ml/min.
Cross-linking reactions. All cross-linking reactions were carried out at 25°C. Samples (usually 50 l [total volume]) contained 50 mM HEPES-NaOH, pH 8.0, and 1 mM bis(sulfosuccinimidyl)suberate (DSS). The reactions were started by addition of protein (25 g), and the reaction mixtures were incubated for 10 and 20 min. The reactions were stopped by addition of gel-loading buffer and immediate incubation in boiling water for 5 min. Samples were analyzed by SDS-PAGE (usually a 10% polyacrylamide resolving gel and a 5% polyacrylamide stacking gel), and the cross-linked and uncross-linked proteins were identified by staining with Coomassie brilliant blue R-250.
Crystallization, X-ray data collection, and fluorescence measurement. For crystallization, the FucO abortive ternary complex was formed by incubation of the purified protein with 4 mM NAD ϩ and 4 mM glycol aldehyde. One microliter of the protein ternary complex (10 mg/ml) in the appropriate buffer was mixed with 1 l of reservoir solution (0.8 M ammonium sulfate, 0.1 M morpholineethanesulfonic acid [MES], pH 6.0), and crystals were grown by the sittingdrop vapor diffusion method at 20°C. Needle-like crystals that were 0.2 by 0.01 by 0.01 mm were cryoprotected with glycerol and flash frozen in liquid nitrogen for data collection at 100 K. The crystals are trigonal and belong to space group P3 1 21, with the following unit cell parameters: a ϭ b ϭ 109 Å and c ϭ 184.4 Å . There are two monomers in the asymmetric unit. An X-ray diffraction data set to 2.75 Å was collected at microfocus beamline ID13 of the ESFR synchrotron light source in Grenoble, France. Due to radiation damage, data were obtained by irradiating the crystal in six different places along the needle. The data were processed with XDS (19) and were merged with XSCALE (19) ( Table 2) . A fluorescence XANES spectrum was recorded around the Fe-K absorption edge (7.122 keV) at beamline ID29, which demonstrated the presence of the metal ion in the crystals.
Structure solution and refinement. The structure of FucO was solved by the molecular replacement method using the program AMoRe (28). The starting model was the structure of the T. maritima 1,3-propanediol dehydrogenase monomer (Protein Data Bank code 1O2D) (37) . Two monomers were clearly identified from the rotation and translation functions in the asymmetric unit. Cycles of model building using TURBO-FRODO (34) were alternated with refinement using the program CNS (8) . Noncrystallographic symmetry restraints were used initially. Bulk solvent correction was applied, and atomic temperature factors were refined. Refinement was completed with a final round performed with REFMAC (27) , including TLS (translation, liberation, and screw rotation). The final monomer included 382 of the 383 amino acids of the chemical sequence, 1 NAD ϩ molecule, 1 Fe 2ϩ ion, and 46 water molecules. The final model has good stereochemical parameters, as analyzed with PROCHECK (22), with no residues in disallowed regions of the Ramachandran plot (Table 2) .
DNA manipulation and site-directed mutagenesis. Bacterial genomic DNA was obtained as described by Silhavy et al. (39) . For large-scale preparation, a crude DNA sample was purified on a column (QIAGEN). DNA manipulations were performed essentially as described by Sambrook and Russell (36) . DNA sequencing was done by using an automated ABI 377 DNA sequencer and fluorescent dye termination methods. DNA fragments were amplified by PCR with E. coli chromosomal DNA as the template. When necessary, specific restriction sites were introduced at the 5Ј end of the primers to facilitate cloning of the fragments in the appropriate vector. PCRs were performed with Pfu DNA polymerase under standard conditions. Site-directed mutagenesis was performed using the QuikChange PCR-based mutagenesis procedure (Stratagene) with pCM2 as the template. The primers used to construct each of the mutants are listed in Table 1 . The appropriate substitutions and the absence of unwanted mutations were confirmed by sequencing the inserts in both directions.
Metal analysis. The Fe and Zn contents of the homogeneous proteins were determined by inductively coupled plasma mass spectrometry with a PerkinElmer Elan-6000. In all cases, prior to metal analysis samples were applied to a Sephadex G-25 PD-10 column (Pharmacia) equilibrated with MilliQ water (resistivity, Ͼ18 M⍀) in order to eliminate reagents and metals not bound to the enzyme. Fractions were collected in metal-free polypropylene tubes. Blank water samples, representing the flowthrough collected in the void volume of the column, were also analyzed, and they contained no significant detectable metal. In all cases, to avoid adsorption of the metalloproteins to the tube walls, samples were sonicated for 5 min before they were digested with 1% nitric acid. Solutions to be tested were adjusted to metal concentrations ranging from 20 to 200 ppb and carried an internal standard (500 ppb of rhodium).
Enzyme and NAD ؉ binding assays. FucO activity was measured by determining NADH-dependent L-lactaldehyde reduction to L-1,2-propanediol using a molar absorption coefficient of 6.22 ϫ 10 Ϫ3 M Ϫ1 cm Ϫ1 at 340 nm and glycol aldehyde as an alternative substrate (9) . The oxidation reaction was measured with L-1,2-propanediol and NAD ϩ as described previously (40) . Kinetic determinations were performed for each condition with eight different concentrations of cofactor bracketing an interval from 37.5 to 250 M. The initial velocities obtained during the first 30 s of the reaction were determined. The K m and V max were determined by linear regression analysis of the data plotted according to the method of Lineweaver and Burk (25) . Parameters were expressed as means for at least three different measurements. For the NAD ϩ loading assays the increase in absorbance at 360 nm was monitored upon stepwise addition of the cofactor to an enzyme suspension (1 mg/ml) in 10 mM Tris-HCl (pH 7.3) that had previously been treated with charcoal to release all bound cofactor. Measurements were performed 10 min after each addition (2) .
Protein structure accession number. The atomic coordinates of FucO have been deposited in the Protein Data Bank under accession code 2bl4.
RESULTS AND DISCUSSION
Structure of FucO monomer. Each FucO subunit consists of a single polypeptide chain of 383 residues composed of 10 ␤ strands (␤1 to ␤10), 16 ␣ helices (␣1 to ␣16), and one 3 10 helix (Fig. 1) . The molecule, like other proteins in the family, folds into two structural domains that are separated by a deep cleft ( Fig. 2A) . The N-terminal domain (residues 1 to 182) is formed by an ␣/␤ region containing the dinucleotide-binding fold, with ␤1 to ␤6 and ␤10 forming the central ␤-sheet, where strand ␤1 is swapped between monomers (see below). Strands ␤2 to ␤6 are connected by helices ␣1 to ␣5, whereas the connection 
, where I i is the ith measurement of reflection I (hkl).
c R factor ϭ ⌺ hkl ԽԽF obs Խ Ϫ k ԽF calc ԽԽ/⌺ hkl ԽF obs Խ. The free R factor is the same for a test set of 5% reflections not used during refinement.
between ␤6 and ␤10 is a long loop that includes an antiparallel ␤-ribbon formed by ␤8 and ␤9. The C-terminal part (residues 183 to 383), in contrast, is an all-helical domain formed by 10 ␣ helices (␣7 to ␣16) with a 3 10 helix (residues 361 to 365) between ␣15 and ␣16. The enzyme forms a dimer in the crystal (Fig. 2B) .
Active site and metal coordination. The two domains define between them a deep cleft where the active center of the enzyme is found. Helix ␣5 together with strands ␤8 and ␤9 of the ␤-ribbon and the intervening loop between ␤7 and ␤8 of the N-terminal domain and helices ␣7, ␣11, and ␣12 of the bundle of the C-terminal domain constitute the opposing faces of the cleft. The location of the binding site for the Fe 2ϩ ion is defined in the face formed by the C-terminal domain. Fe 2ϩ is tetrahedrally coordinated through an ion dipole interaction with residues Asp196, His200, His263, and His277 (Fig. 3) . In a previous study (30) His267 was also thought to be involved in Fe 2ϩ binding, but mutation of this residue did not significantly affect the metal ion binding. In this previous study, participation of His263 and His277 was also proposed and demonstrated by site-directed mutagenesis. In the present structure His267 is not coordinated with the Fe 2ϩ ion. As discussed FIG. 1. Sequence alignment of several group III iron-dependent alcohol dehydrogenases. Amino acid sequences are shown for lactaldehyde: 1,2-propanediol oxidoreductase from E. coli (FucO) (accession no. P11549), 1,2-propanediol dehydrogenase from S. enterica serovar Typhimurium (1,2-Prd) (accession no. Q8ZMC8), alcohol dehydrogenase II from Z. mobilis (ADH2) (accession no. P06758), 1,3-propanediol oxidoreductase from K. pneumoniae (1,3-Prd) (accession no. Q59477), and alcohol dehydrogenase IV from S. cerevisiae (ADH4) (accession no. P10127). Amino acid residues that are identical in all sequences are indicated by red shading. Residues that are conserved are indicated by red type and enclosed in blue boxes. The secondary structure of FucO is shown above the sequences. Green circles indicate residues that interact with the NAD ϩ cofactor. Blue circles indicate residues that coordinate the Fe 2ϩ ion. The black triangle indicates an essential histidine, which putatively interacts with the substrate.
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below, this residue seems to be a good candidate to interact with the substrate, which would be consistent with the inactivation observed when it is mutated. Participation of His263 and His277 in the metal coordination was also proposed in the previous study and was demonstrated by site-directed mutagenesis. In the present work we mutated the two other Fe 2ϩ binding residues, Asp196 and His200. Mutant FucO proteins bearing the mutation D196L, H200A, or H200F were purified, and their metal contents were determined. The three mutants
were not able to bind Fe 2ϩ and had iron contents of less than 0.01 atom/subunit, whereas wild-type FucO protein, which was examined in parallel as a control, had 0.53 atom/subunit. (Fig. 4) .
Location of the cofactor binding site and NAD
؉ specificity. The crystals grew in the presence of 2 mM NAD ϩ , and both the 2Fo-Fc and Fo-Fc Fourier maps clearly showed the presence of the cofactor molecule (Fig. 5A) . The cofactor binds in the cleft defined by the two domains interacting mainly with residues of the N-terminal domain (Fig. 5B) . The adenine ring interacts with Thr140 of the N-terminal domain and Met181 of ␣6 at the intervening sequences between domains, located at the upper end of the cleft. The exocyclic nitrogen at C-6 of the six-member ring of the purine interacts with the carbonyl oxygens of Thr140 and Met181, while N-7 of the five-member ring of the purine interacts with the side chain oxygen of Thr140 (Fig. 6) . The hydroxyl group at position 2 of the adenine ribose is hydrogen bonded with the carboxyl of the side chain of Asp39 at the end of strand ␤3. Interactions with the pyrophosphate group include the following hydrogen bonds: the adenine-proximal phosphate interacts with Ser99 of ␣5, and the adenine-distal phosphate interacts with Thr141 and with the nitrogen amide atom of Gly98 in the glycine-rich turn formed by residues 96 to 98 (Fig. 6) .
This glycine-rich motif and a following ␣ helix are part of the NAD ϩ recognition locus in the dehydrogenases, which have a typical dinucleotide-binding fold. However, in the FucO sequence there is another glycine-rich motif (GXGXXG) between residues 15 and 20, which has been reported to be part of the recognition site for many dehydrogenases (31, 38, 45) . To assess the participation of this glycine-rich motif in the recognition of NAD ϩ by FucO, we obtained by site-directed mutagenesis two mutant FucO clones, one containing the mutation G97E and the other containing the mutation G17D. The G97E mutation completely abolished FucO activity, whereas G17D did not affect it significantly. Furthermore, the NAD ϩ binding capacity was measured for the two mutant enzymes and compared to that of wild-type FucO. Both the wild-type enzyme and the G17D mutant enzyme bound NAD ϩ up to saturation (2 mol of NAD ϩ per mol of protein) upon addition of the cofactor to an NAD ϩ unloaded preparation (Fig. 7) . In contrast, mutant G97E did not bind a significant amount of NAD ϩ . Thus, we concluded that of the two glycine-rich motifs that might interact with the cofactor, only the one between positions 96 and 98 is relevant to NAD ϩ binding. In addition, this is consistent with the location of NAD ϩ in the structure of the enzyme-cofactor complex, as determined in this study.
The nicotinamide ribose O-2 hydroxyl group forms a hydrogen bond with the nitrogen atom of the side chain of the conserved Lys162 residue. The nicotinamide ring lies in a hydrophobic pocket formed by Val164, Phe254, Val153, Leu189, Met185, Pro186, and Leu42, among others (Fig. 6) , with the C-4 and C-5 ring atoms in close proximity to the Fe 2ϩ . The nicotinamide ring orientation in the FucO active center facilitates hydride transfer to the A face of the ring during the enzyme's catalytic cycle. It should be emphasized that when the locations of the nicotinamide ring in FucO and in the 1,3-propanediol dehydrogenase of T. maritima (37) are compared, a significant difference in orientation is detected as the ring is closer to the N terminal domain in the T. maritima enzyme (Fig. 5B) . The flexibility of the nicotinamide nucleotide moiety in the NAD ϩ molecule permits a certain mobility in this part of the cofactor molecule in a space large enough to allow the movement required for the correct location of the substrate and may explain the weakness of the electron density observed in the nicotinamide area.
FucO is an NAD ϩ or NADH enzyme, depending on the oxidation or reduction in its catalytic cycle. Analysis of the structure clearly indicates that its inability to use NADP(H) is due to steric hindrance of the 2Ј phosphate of the adenosine moiety with Asp39. Consistently, one of the structural differences between FucO and the NADP(H)-dependent enzyme from T. maritima is that in the latter, residue 39 corresponds to a glycine. We mutated the Asp39 of FucO to glycine. The D39G mutant protein allowed utilization of NADP(H), and, as expected, this mutant enzyme also had the capacity to use NAD(H). To check the catalytic efficiency of the mutant enzyme with either of the two cofactors, we examined the concentration kinetics of the reduction reaction for the wild-type and mutant enzymes. As shown in Table 3 , the affinity of the mutant FucO for NADP(H) was similar to the affinity either of the mutant or of the wild-type enzyme for NAD(H). Nevertheless, the K cat of the mutant enzyme was lower for NADP(H). These results indicated that the D39G mutation allows FucO to use NADP(H) as a cofactor, although the catalytic efficiency is slightly lower. Rosell et al. (33) , working with ADH8, an amphibian NADP(H)-dependent dehydrogenase, showed by site-directed mutagenesis that several amino acids (namely, Gly223-Thr224-His225 and a conserved Lys228) define a binding pocket for the terminal phosphate of NADP(H). Close inspection of the residues in the vicinity of Asp39 of our enzyme allowed us to identify a group of residues (Lys40, Thr41, and Gln44) that seem to mimic this binding pocket for the terminal phosphate. This observation may explain the similar affinity of the cofactor center for the spurious NADP(H) or the physiological NAD(H), provided that the steric and electrostatic hindrance with Asp39 is eliminated by mutating this amino acid to glycine. At present, we cannot explain why the mutation lowers the V max of the reaction.
Location of the substrate binding site. Although we grew crystals of FucO in the presence of up to 2 mM glycol aldehyde as a substrate to form the abortive ternary complex with NAD ϩ , in no case could an electron density corresponding to the glycol aldehyde be found on the Fourier maps. Docking of the substrate molecule L-1,2-propanediol (Fig. 3) in the active center resulted in a model in which the O-1 hydroxyl of the substrate interacts with the Fe 2ϩ ion. In this model His267 does not interact directly with the substrate (both the O-1 and O-2 hydroxyl oxygens of the substrate are 4.2 Å from the N ε2 nitrogen of His267), but a water-mediated hydrogen bond is possible. The loss of the latter interaction may explain the inactivation of enzyme activity when this residue is mutated to alanine (30) .
As indicated above, the space available at the area around the location of the nicotinamide moiety of NAD ϩ allows a certain mobility of the ring, opening several possibilities for modeling entry of the substrate. The position of the L-1,2-propanediol substrate was determined by examining the position of the substrate glycerol in the very similar active center of the glycerol dehydrogenase of B. stearothermophilus (35) . In this model the nicotinamide ring of the cofactor was slightly pulled toward the C-terminal domain face of the intermediate cleft of the protein structure. The docking of the substrate caused close approach of the C-1 hydroxyl of the substrate to C-4 of the nicotinamide ring (3.1 Å ) and to the Fe 2ϩ ion (3.3 Å between the L-1,2-propanediol C-1 and Fe 2ϩ or 2.6 Å between the corresponding hydroxyl O-1 and Fe 2ϩ ), an appropriate arrangement for a typical metal-dependent dehydrogenation catalytic mechanism. In such a mechanism the Fe 2ϩ ion lowers the pK a of the C-1 hydroxyl, and the hydride is thus transferred to C-4 of the nicotinamide ring.
Quaternary structure of FucO. Since the FucO protein molecular mass, as estimated by gel filtration, has been reported to be close to 80,000 Da, it has been generally accepted that native FucO in E. coli is a dimeric protein (6, 24) . The presence of homodimers in FucO purified preparations is consistent with the dimeric arrangement observed in the crystal structure (Fig. 2B) . The two monomers of the dimer are related by a twofold noncrystallographic symmetry axis. The interface area between the two monomers (1,094 Å 2 ) is indicated in Fig. 8A , and there are several possible interactions, which are mainly hydrophobic, with some hydrogen bonds and salt bridges. The dimer is maintained mainly by the swapping of strand ␤1 between monomers, leading on each subunit to a 10-strand ␤-sheet in which the first strand belongs to the partner monomer (Fig. 2B) . Besides the ␤-sheet-type H-bonding interactions between strands ␤1 and ␤2 (residues 4 to 14) of the N-terminal domain, additional contacts between the ␣8 and ␣10 helices (residues 212 to 226 and 237 to 254, respectively) of the C-terminal domain are observed.
The key role of the N-terminal ␤ strands was confirmed by studying the dimerization of a mutant enzyme with residues 1 to 10 of the FucO sequence deleted. The sequence modification in this mutant, which exhibited no oxidoreductase activity, greatly diminished the estimated interface area according to the GRASP program (29) (Fig. 8B) . The differences in oligomeric states between the wild-type FucO and the ⌬N10 mutant FucO were analyzed by size exclusion chromatography. The apparent molecular mass derived from the elution volume of the wild-type FucO corresponded to a dimer, whereas the elution volume of the mutant FucO corresponded to a monomer (not shown). The oligomeric states were also established in cross-linking experiments with DSS. These experiments revealed no band with the dimer mobility in the PAGE lane corresponding to the mutant, which contrasted with the band observed in the lane corresponding to the wild-type enzyme, thus indicating that there was a significant decrease in the dimerization capacity of the mutant enzyme (Fig. 8C) . Note that the ⌬N10 mutant FucO is more sensitive to degradation by the cross-linker than the wild-type enzyme.
Structural comparison with other proteins. Group III "ironactivated" alcohol dehydrogenases from E. coli and its orthologs form a conserved family of microbial enzymes. A BLAST search analysis of the amino acid sequence of the E. coli FucO showed similarity with various iron-dependent group III dehydrogenases, such as 1,2-propanediol dehydrogenase from Salmonella enterica serovar Typhimurium (accession no. Q8ZMC8), alcohol dehydrogenase II from Zymomonas mobilis (accession no. P06758), 1,3-propanediol oxidoreductase from K. pneumoniae (accession no. Q59477), and alcohol dehydrogenase IV from Saccharomyces cerevisiae (accession no. P10127). Analysis of these sequences showed that the largest number of strictly conserved residues is at the active site involved in metal coordination or in cofactor binding (Fig. 1) .
A structural comparison using the DALI server (17) of E. coli FucO and other protein structures revealed that the most structurally similar proteins were (i) the putative 1,3-propanediol dehydrogenase TM0920 from T. maritima (PDB accession code 1O2D) with a root mean square deviation of 2.0 Å for the superimposition of 344 C␣ atoms and 28% sequence identity and (ii) the alcohol dehydrogenase YqhD from E. coli (PDB accession code 1OJ7) with an rmsd of 2.5 Å for the superimposition of 372 C␣ atoms and 24% sequence identity. Both of these structures have a highly analogous N-terminal domain consisting of an ␣/␤ region containing the dinucleotide-binding fold and a C-terminal all-helix domain. The fold of the second domain is characteristic of the group III metaldependent alcohol dehydrogenases and has not been reported in any other type of protein. The interactions of two monomers through N-terminal ␤-strand swapping (␤1 and ␤2) together with the ␣-helical contacts mentioned above are also found in the T. maritima TM0920 and E. coli YqhD enzymes. Analysis of the structure of the glycerol dehydrogenase of B. stearothermophilus also showed this form of monomer-monomer interaction. We concluded that this model of dimerization constitutes a specific feature of most of the proteins reported to belong to the group III metal-dependent dehydrogenases. On the other hand, as noticed by Sulzenbacher et al. (42) , A. nidulans dehydroquinate synthase (13) (PDB accession code 1DQS), which has a similar monomer fold (rmsd, 3.0 Å ; 14% sequence identity), does not show the N-terminal ␤-strand swapping. Therefore, the 10-strand ␤-sheet is formed by elements that all belong to the same monomer. Strand 1 is thus not extended out of the sheet but is folded over strand 2. Superposition of the 1DQS structure with our structure indicated that in the former, the swapped conformation is not possible because ␤1 would clash with a loop of the all-␣-helix C terminus at residues 255 and 256. Among the members of this group, dehydroquinate synthase shows the lowest sequence similarity and a distinct catalytic activity and is therefore the most distantly related.
Domain or secondary structure element swapping has been proposed as a rapid mechanism for the evolution from monomeric to oligomeric proteins (4, 12) . Because it is based on the interchange of identical structural elements, the resulting interactions are guaranteed, as occurs with the ␤-sheet hydrogen bonds in the present structure. Additional interactions can be gained from mutations that reinforce the union, leading finally to a new interface between subunits. It is clear, however, that evolution to dimeric forms can follow completely different paths in closely related proteins, as shown for the 1DQS protein. An open question is whether there are any subtle structure determinants that drive molecular evolution one way or the other.
